# A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension

> **NCT00173667** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 60 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nifedipine 30 mg GITS

## Key facts

- **NCT ID:** NCT00173667
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00173667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00173667, "A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00173667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*